BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37784000)

  • 1. The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kawahara S; Cho H; Morita J; Segami K; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
    J Gastrointest Cancer; 2024 Mar; 55(1):383-390. PubMed ID: 37784000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative Gastrectomy.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Otani K; Sawazaki S; Cho H; Morita J; Kawahara S; Tanabe M; Yukawa N; Saito A; Ogata T; Rino Y; Oshima T
    J Gastrointest Cancer; 2024 Mar; 55(1):402-409. PubMed ID: 37889434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
    Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
    PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.
    Wu M; Pan Y; Jia Z; Wang Y; Yang N; Mu J; Zhou T; Guo Y; Jiang J; Cao X
    Dis Markers; 2019; 2019():9060845. PubMed ID: 31781312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.
    Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Yamada T; Maezawa Y; Hara K; Hashimoto I; Suematsu H; Watanabe H; Takahashi K; Numata M; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
    In Vivo; 2021; 35(6):3475-3482. PubMed ID: 34697184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Impact of the Prognostic Immune and Nutritional Index in Gastric Cancer Patients Who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
    Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
    World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
    Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
    Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative C-reactive protein-to-albumin ratio and clinical outcomes after resection of colorectal liver metastases.
    Sakamoto Y; Mima K; Imai K; Miyamoto Y; Tokunaga R; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Nagai Y; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Baba H
    Surg Oncol; 2020 Dec; 35():243-248. PubMed ID: 32932221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the preoperative C-reactive protein-to-albumin ratio in patients with colorectal cancer.
    Tamagawa H; Aoyama T; Numata M; Maezawa Y; Kazama K; Astumi Y; Hara K; Kano K; Yukawa N; Saeki H; Godai T; Oshima T; Goda M; Rino Y; Masuda M
    J Cancer Res Ther; 2021; 17(4):1075-1080. PubMed ID: 34528567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.
    Kuroda D; Sawayama H; Kurashige J; Iwatsuki M; Eto T; Tokunaga R; Kitano Y; Yamamura K; Ouchi M; Nakamura K; Baba Y; Sakamoto Y; Yamashita Y; Yoshida N; Chikamoto A; Baba H
    Gastric Cancer; 2018 Mar; 21(2):204-212. PubMed ID: 28656485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
    BMC Cancer; 2020 Jan; 20(1):11. PubMed ID: 31906893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]   [Full Text] [Related]  

  • 15. Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer.
    Sun F; Ge X; Liu Z; Du S; Ai S; Guan W
    World J Surg Oncol; 2017 Oct; 15(1):191. PubMed ID: 29065877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer.
    Bao Y; Yang J; Duan Y; Chen Y; Chen W; Sun D
    Biosci Trends; 2021 Jan; 14(6):428-435. PubMed ID: 33239498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
    Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of preoperative C-reactive protein to albumin ratio in patients with thymic epithelial tumors: a retrospective study.
    Huang YY; Liu X; Liang SH; Hu Y; Ma GW
    BMC Cancer; 2022 Nov; 22(1):1183. PubMed ID: 36397047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.